QuidelOrtho Corporation Common Stock

QDEL XNAS IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Market Cap

910M

Short interest (May 15)

17.3%

Net Short (Jun 03 ): 0.1%

Borrow Fee

0.40%

↓ 2.8%

Available Shares

400K

↑ 13.5%

Price Chart

Company Overview

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

Company Info

Exchange: NASDAQ
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CIK: 0001906324
Asset Type: CS

Market Data

Market Cap: $906,258,243
Employees: 6,500
Status: Active

Short Interest

Current Borrow Fee 0.40%
Range: 0.40% - 0.40%
Available Shares 400K
Range: 350K - 350K

Recent Changes

Fee Change: ↓ 0.1%
Available Change: ↑ 7.7%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime